Fidelis Capital Partners LLC Has $615,000 Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fidelis Capital Partners LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,824 shares of the medical equipment provider’s stock after acquiring an additional 80 shares during the period. Fidelis Capital Partners LLC’s holdings in Intuitive Surgical were worth $615,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 0.7% in the 3rd quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after buying an additional 196,316 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Intuitive Surgical by 1.0% during the 1st quarter. Geode Capital Management LLC now owns 6,444,995 shares of the medical equipment provider’s stock worth $1,642,287,000 after buying an additional 61,659 shares during the last quarter. Morgan Stanley lifted its holdings in shares of Intuitive Surgical by 29.9% during the fourth quarter. Morgan Stanley now owns 5,866,613 shares of the medical equipment provider’s stock worth $1,556,706,000 after buying an additional 1,351,002 shares in the last quarter. Jennison Associates LLC increased its stake in Intuitive Surgical by 6.4% during the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock worth $1,340,205,000 after acquiring an additional 274,692 shares during the period. Finally, Invesco Ltd. lifted its stake in Intuitive Surgical by 6.6% during the third quarter. Invesco Ltd. now owns 3,750,490 shares of the medical equipment provider’s stock worth $1,096,231,000 after purchasing an additional 232,205 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Down 1.5 %

Intuitive Surgical stock traded down $5.48 during mid-day trading on Friday, reaching $367.15. 1,221,418 shares of the company’s stock traded hands, compared to its average volume of 1,637,508. The stock has a 50 day moving average of $387.27 and a two-hundred day moving average of $342.60. The company has a market cap of $130.14 billion, a price-to-earnings ratio of 75.96, a PEG ratio of 5.81 and a beta of 1.36. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The company had revenue of $1.89 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same period last year, the company posted $1.00 earnings per share. Intuitive Surgical’s revenue was up 11.5% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now directly owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, Director Alan J. Levy sold 2,000 shares of the business’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.20, for a total value of $740,400.00. Following the completion of the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Gary S. Guthart sold 24,325 shares of Intuitive Surgical stock in a transaction that occurred on Monday, January 29th. The shares were sold at an average price of $376.06, for a total value of $9,147,659.50. Following the transaction, the chief executive officer now owns 9,425 shares of the company’s stock, valued at $3,544,365.50. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 248,418 shares of company stock valued at $95,927,097. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of recent analyst reports. Citigroup lifted their price objective on Intuitive Surgical from $428.00 to $462.00 and gave the stock a “buy” rating in a research note on Wednesday, April 3rd. Truist Financial increased their price target on Intuitive Surgical from $390.00 to $435.00 and gave the stock a “buy” rating in a research note on Wednesday, January 24th. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Jefferies Financial Group raised their price target on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday. Finally, Wells Fargo & Company increased their target price on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research note on Friday, January 19th. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $378.48.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.